Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000061

Chief Executive Officer bought 2,000 shares at $12.89 ($25,780)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Congleton Jon Chief Executive Officer 2023-08-11 Purchase +2,000 $12.89 $25,780 1,040,318 D
Open-market purchases · 2,000 sh · avg $12.89 · $25,780
Loading xslF345X05/wf-form4_169179546088184.xml…